Showing 6 of 6 recruiting trials for “lymphomatoid-papulosis”
Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of New Diagnosed AITL
A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITL
A Study of Enasidenib in People With T-Cell Lymphoma
👨⚕️ Zachary Epstein-Peterson, MD, Memorial Sloan Kettering Cancer Center📍 8 sites📅 Started Dec 2024View details ↗
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
RecruitingNCT02840747 ↗
Tissue Repository: CTCL Collection Protocol
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →